Metoprolol (Tartrate) Overview Categories 12 Cardiovascular drugs12.3 Anti-hypertensives12.3.1 Beta blocking agents Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Hexobarbitone (Na) Manufacturers of Hexobarbitone (Na) Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Hexobarbitone (Na)'s dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 5 mg5 (5)As recommended.IVFor Cardiac Arrythmia rate is 2mg/min may be repeated at intervals of 5 min to a total dose of 10-15 mg .Maintainence therapy dose should not exceed than 50 mg (PO) given 3 times a day ,4 to 6 hrz after IV therapy12.5 to 25 mg19 (18.75)As recommended.POIn management of symptomatic heart failure.50 to 100 mg75 (75)12 hourlyPOFor Angina Pectoris For emergency treatment.100 to 200 mg150 (150)As recommended.POMigtaine prephylaxi''s100 to 200 mg150 (150)24 hourlyPOFor Hypertension Initially given 100 mg.Maintainance dose is 200 mg Can be increased up to 400 mg50 to 300 mg180 (175)8 hourlyPOFor Cardiac Arrythmia Paedriatic Dosage (20kg) 2.5 to 4 mg/kg3.2 (3.25)12 hourlyOral- Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Hexobarbitone (Na) is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Hexobarbitone (Na) Back to top Manufacturers of Metoprolol (Tartrate) in Pakistan Akson Atco Barrett Batala CCL Fynk Genix Hygeia Mass MBL Mega Pharma Novartis Obsons Raazee Scotmann Unimark Back to top Previous Drug Generic - Next Drug Generic